Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 58 of 61 for:    Lixisenatide

Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents (LixiLan-D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03434119
Recruitment Status : Terminated (("Trial terminated (recruitment delays)"))
First Posted : February 15, 2018
Last Update Posted : January 29, 2019
Sponsor:
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 9, 2019
Actual Study Completion Date : January 9, 2019